Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Merck
Dow
Harvard Business School
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for ALLERGAN, INC. v. HI-TECH PHARMACAL CO., INC. (M.D.N.C. 2011)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ALLERGAN, INC. v. HI-TECH PHARMACAL CO., INC. (M.D.N.C. 2011)

Docket   Start Trial Date Filed 2011-08-17
Court District Court, M.D. North Carolina Date Terminated 2013-01-25
Cause 35:271 Patent Infringement Assigned To Catherine Caldwell Eagles
Jury Demand Both Referred To MAG/JUDGE L. PATRICK AULD
Parties ALLERGAN, INC.; APOTEX CORP.; APOTEX, INC.; DUKE UNIVERSITY; HI-TECH PHARMACAL CO., INC.; SANDOZ, INC.
Patents 6,403,649; 7,351,404; 7,388,029
Attorneys A. MARTINA HUFNAL; BRYAN G. SCOTT; DAVID MATTHEW WILKERSON; DEANNA J. REICHEL; DOUGLAS E. MCCANN; ELIZABETH M. FLANAGAN; JEFFREY DEAN PATTON; JOEL M. WALLACE; JONATHAN E. SINGER; JUANITA R. BROOKS; LARRY STEPHEN MCDEVITT; LYN K. BROOM; ROBERT M. OAKES; ROGER A. DENNING; SAILESH K. PATEL; STEVEN BRIAN FOX; STEVEN ROTH
Link to Docket External link to docket
Small Molecule Drugs cited in ALLERGAN, INC. v. HI-TECH PHARMACAL CO., INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for ALLERGAN, INC. v. HI-TECH PHARMACAL CO., INC. (M.D.N.C. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-08-17 1 Complaint States Patent Nos. 7,351,404 (“the ’404 patent”), 7,388,029 (“the ’029 patent”), and 6,403,649 (“the … Listed Patents are the ’404,’029, and ’649 patents. The FDA has published the Listed Patents in the …title, and interest in the ’404 patent. 16. The ’029 patent, entitled “Compositions and Methods…the ’029 patent. 18. Allergan is an exclusive field licensee of the ’029 patent. …Allergan has listed with the FDA three patents (the “Listed Patents”) that cover the approved formulation External link to document
2012-02-01 41 Stipulation of Dismissal Plaintiffs' Count III With Respect to U.S. Patent No. 6,403,649 by ALLERGAN, INC., DUKE UNIVERSITY, HI-TECH…2011 25 January 2013 1:11-cv-00650 830 Patent Both District Court, M.D. North External link to document
2012-04-20 50 Statement Claim Construction Statement Regarding U.S. Patent Nos. 7,351,404 and 7,388,029 Under Local Rule 104.3 by …2011 25 January 2013 1:11-cv-00650 830 Patent Both District Court, M.D. North External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
McKinsey
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.